Drugs / GPO-Vir Z30 tablet
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00672412 | Oct 2008 → Jan 2010 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GPO-Vir Z30 tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00672412 ↗ |
| Route | Oral | “taken orally twice daily” NCT00672412 ↗ |